酚妥拉明联合阿拉明治疗小儿肺炎并发心力衰竭的临床效果分析  

Phentolamine combined with aramine in treatment of pediatric pneumonia complicated with heart failure

作　　者：叶天然 

机构地区：[1]湖北省黄冈市罗田县人民医院儿科,438600

出　　处：《国际医药卫生导报》2016年第8期1136-1138,共3页International Medicine and Health Guidance News

摘　　要：目的评价酚妥拉明联合阿拉明治疗小儿肺炎并发心力衰竭的临床效果。方法选取2008年6月至2015年6月于本院接受治疗的小儿肺炎并发心力衰竭患儿180例，随机分为对照组（90例）和观察组（90例），其中对照组给予强心、平喘、利尿、氧疗等常规治疗，观察组在对照组基础上酚妥拉明联合阿拉明治疗。比较两组治疗效果。结果观察组心力衰竭控制时间、热退时间、喘息症状消失时间、哕音消失时间及住院天数均显著短于对照组（P〈0．05）；观察组治疗总有效率（95．56％）显著高于对照组（76．67％）（P〈0．05）；两组治疗期间均未出现严重不良反应。结论酚妥拉明联合阿拉明治疗小儿肺炎并发心力衰竭，疗效确切，且无严重不良反应，值得在临床上推广应用。Objective To evaluate the clinical effect of phentolamine combined with aramine in the treatment of pediatric pneumonia complicated with heart failure. Methods 180 children with pneumonia complicated with heart failure treated at our hospital from June, 2008 to June, 2015, were randomly divided into a control group （90 cases） and an observation group （90 cases）. The control group received conventional therapy, such as cardiotonic, antiasthma, diuresis, oxygen therapy, etc.; in addition, the observation group was treated with phentolamine and aramine. The efficacies were compared between these two groups. Results The time for controlling heart failure, defervescence time, asthmatic symptom disappearance time, rales disappearance time, and hospital stay were significantly shorter in the observation group than in the control group （P〈0.05）. The total effective rate was significantly higher in the observation group than in control group （95.56% vs. 76.67%, P〈0.05）. No serious adverse reactions occurred in both groups during the treatment. Conclusions Phentolamine combined aramine in the treatment of pediatric pneumonia complicated with heart failure is effective and has no serious adverse reactions. It is worth being clinically generalized.

关 键 词：小儿肺炎并发心力衰竭 酚妥拉明 阿拉明 联合用药 疗效 

分 类 号：R541.4[医药卫生—心血管疾病]